ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
36.82
0.00%
US Tech 100
19,020.00
0.10%
S&P 500
5,554.25
0.00%
US Dollar vs CAD
1.36756
-0.04%
Bitcoin
58,441.91
-0.26%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Amneal Pharmaceuticals Holding Co (AMRX)

  7. Amneal Pharmaceuticals Holding Co (AMRX) News

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Holding Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:AMRX
DateTimeSourceHeadlineSymbolCompany
08/14/20242:12PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/14/202410:04AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/14/20244:56AMIH Market NewsUBS Beats Earnings Forecasts, Intel Divests Arm Holdings, Flutter Surges 9% in Premarket Trading, and MoreNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/09/20245:05AMBusiness WireAmneal Reports Second Quarter 2024 Financial ResultsNYSE:AMRXAmneal Pharmaceuticals Holding Co
08/07/20243:45PMBusiness WireAmneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release CapsulesNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/29/20243:05PMBusiness WireAmneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV BagsNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/11/20243:05PMBusiness WireAmneal to Report Second Quarter 2024 Results on August 9, 2024NYSE:AMRXAmneal Pharmaceuticals Holding Co
07/09/20243:05PMBusiness WireAmneal Launches FOCINVEZ™, the First Ready-to-Use Version of FosaprepitantNYSE:AMRXAmneal Pharmaceuticals Holding Co
07/01/20247:00AMBusiness WireKashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)NYSE:AMRXAmneal Pharmaceuticals Holding Co
07/01/20247:00AMBusiness WireAmneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab BiosimilarNYSE:AMRXAmneal Pharmaceuticals Holding Co
06/28/20247:00AMBusiness WireAmneal Releases 2023 Environmental, Social and Governance ReportNYSE:AMRXAmneal Pharmaceuticals Holding Co
06/05/20247:00AMBusiness WireAmneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New TherapiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/22/20243:05PMBusiness WireAmneal to Participate at Upcoming Investor ConferenceNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/22/20243:05PMBusiness WireAmneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of CaliforniaNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/16/20242:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/16/20242:13PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/14/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/14/20243:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/14/20243:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/14/20243:42PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/07/20243:18PMEdgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/20244:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/20244:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/06/20244:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/03/20245:14AMEdgar (US Regulatory)Form 8-K - Current reportNYSE:AMRXAmneal Pharmaceuticals Holding Co
05/03/20245:00AMBusiness WireAmneal Reports First Quarter 2024 Financial ResultsNYSE:AMRXAmneal Pharmaceuticals Holding Co
04/24/20247:00AMBusiness WireAmneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid OverdoseNYSE:AMRXAmneal Pharmaceuticals Holding Co
04/16/20247:00AMBusiness WireAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable MedicineNYSE:AMRXAmneal Pharmaceuticals Holding Co
 Showing the most relevant articles for your search:NYSE:AMRX

Your Recent History

USOTC
ERHE
ERHC Energy (CE)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
SHIBUSD
SHIBA INU
USOTC
BABLD
NFT MarketPlace (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
SPZI
Spooz (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
VDRM
ViaDerma (PK)
USOTC
RONN
Ronn Motor (PK)
NASDAQ
COOP
Mr Cooper
USOTC
AHRO
Authentic (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved